MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a neurodegenerative disorder that has cerebral effects such as neurovascular dysfunction [70], cognitive decline, accumulation of amyloid-β-peptide-Aβ, and also tau-related lesions in neurons, also called neurofibrillary tangles [71].